HDMA - Position Statements - Suggested Manufacturer Price Change Notification Policies and Procedures

Anti-Counterfeiting Controlled Substances Emergency Preparedness Flu Vaccine HDMA PAC HDMA State LawBooks Log Into HDMA State LawBooks Importation Internet Pharmacy Legislative Center Patient Privacy and Confidentiality Prescription Drug Pedigree Requirements Tax Legislation Additional HDMA Federal Agency Activities News Center Press Room Vital Link Annual Leadership Forum Distribution Management Conference & Expo Business Partners Exchange Regional Roundtable Meetings RFID/Track & Trace Health Care Summit Upcoming Meetings & Conferences Webinars Education Webinars Seminars Anti-Counterfeiting Barcoding Biotechnology Contract
Administration/Chargebacks Controlled Substances Ordering
System (CSOS) Electronic Data Interchange (EDI) Electronic Product Code (EPC) Product Availability/Drug Shortages HDMA Distribution Digest HDMA New Rx Product Introduction Form HDMA State LawBooks Log Into HDMA State LawBooks Industry Acronyms Industry Analysts Industry News Links Industry Statistics Industry Web Links Links to State Legislatures Award Programs Member Companies HDMA Directory HDMA Antitrust Policy Sponsorship Opportunities Advertising Opportunities



> HDMA Testifies Supporting HR5839 > HDMA Applauds Introduction of HR 5839 > HDMA Applauds NCPA, FBI LEEDA and Purdue Pharma > HDMA Commends California Board of Pharmacy Decision > New Data Management & Sharing Research Now Available! print page

Position Statements

Suggested Manufacturer Price Change Notification Policies and Procedures

HDMA believes that manufacturers' policies and procedures must ensure that all classes of trade and individual customers are treated fairly and equitably when price changes are announced. HDMA encourages a system that is least disruptive to normal business functions and is equal and proportionate for all.